PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia

Risk categories and refractory CLL in the era of chemoimmunotherapy

(2012) T. Zenz et al.   BLOOD

Soluble CD200 Is Critical to Engraft Chronic Lymphocytic Leukemia Cells in Immunocompromised Mice

(2012) K. K. Wong et al.   CANCER RESEARCH

The androgen/androgen receptor axis in prostate cancer

(2012) Eric G. Bluemn et al.   CURRENT OPINION IN ONCOLOGY

Therapeutic targets in cancer cell metabolism and autophagy

(2012) Heesun Cheong et al.   NATURE BIOTECHNOLOGY

Drug-mediated inhibition of Fli-1 for the treatment of leukemia

(2012) Y-J Li et al.   Blood Cancer Journal

Aberrant interferon-signaling is associated with aggressive chronic lymphocytic leukemia

(2011) J. Tomic et al.   BLOOD

PPARs and Lipid Ligands in Inflammation and Metabolism

(2011) Gregory S. Harmon et al.   CHEMICAL REVIEWS

Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets

(2011) R. D. Michalek et al.   JOURNAL OF IMMUNOLOGY

Flicking the Warburg Switch—Tyrosine Phosphorylation of Pyruvate Dehydrogenase Kinase Regulates Mitochondrial Activity in Cancer Cells

(2011) Almut Schulze et al.   MOLECULAR CELL

Research Resource: Comparative Nuclear Receptor Atlas: Basal and Activated Peritoneal B-1 and B-2 Cells

(2011) Cody J. Diehl et al.   MOLECULAR ENDOCRINOLOGY

The lymph node microenvironment promotes B-cell receptor signaling, NF- B activation, and tumor proliferation in chronic lymphocytic leukemia

(2010) Y. Herishanu et al.   BLOOD

Pharmacodynamics and Pharmacokinetics of AM103, a Novel Inhibitor of 5-Lipoxygenase-Activating Protein (FLAP)

(2010) G Bain et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

VLDL hydrolysis by LPL activates PPAR-α through generation of unbound fatty acids

(2010) Maxwell A. Ruby et al.   JOURNAL OF LIPID RESEARCH

A novel Rag2-/- c-/--xenograft model of human CLL

(2009) M. T. S. Bertilaccio et al.   BLOOD

Prolonging microtubule dysruption enhances the immunogenicity of chronic lymphocytic leukaemia cells

(2009) S. P. Shaha et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction

(2009) Ismael Samudio et al.   JOURNAL OF CLINICAL INVESTIGATION

Glucose represses PPARαgene expression via AMP-activated protein kinase but not via p38 mitogen-activated protein kinase in the pancreatic β-cell

(2009) Erik JOLY et al.   Journal of Diabetes

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

(2008) M. Hallek et al.   BLOOD

CD54 is a surrogate marker of antigen presenting cell activation

(2008) N. A. Sheikh et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation

(2008) Ralph J. DeBerardinis et al.   Cell Metabolism

Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells

(2008) A.S. Pimenta et al.   JOURNAL OF CELLULAR PHYSIOLOGY